{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:28:44Z","timestamp":1788953324442,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","award":["15\/0005284 (H.Chichger"],"award-info":[{"award-number":["15\/0005284 (H.Chichger"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.exer.2020.108104","type":"journal-article","created":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T18:20:13Z","timestamp":1591467613000},"page":"108104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Lutein and zeaxanthin attenuates VEGF-induced neovascularisation in human retinal microvascular endothelial cells through a Nox4-dependent pathway"],"prefix":"10.1016","volume":"197","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6474-6563","authenticated-orcid":false,"given":"Gianne","family":"Keegan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahina","family":"Pardhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Havovi","family":"Chichger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2020.108104_bib1","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/IAE.0b013e3182721153","article-title":"Intravitreal bevacizumab in the treatment of diabetic ocular neovascularization","volume":"33","author":"Ababneh","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.exer.2020.108104_bib2","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/eye.2015.64","article-title":"Sustained supplementation and monitored response with differing carotenoid formulations in early age-related macular degeneration","volume":"29","author":"Akuffo","year":"2015","journal-title":"Eye"},{"key":"10.1016\/j.exer.2020.108104_bib3","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3109\/09637486.2010.488638","article-title":"The carotenoids of some food stuffs in Saudi Arabia","volume":"61","author":"Al-Ahmary","year":"2010","journal-title":"Int. J. Food Sci. Nutr."},{"key":"10.1016\/j.exer.2020.108104_bib4","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/ceo.13155","article-title":"Effect of NADPH oxidase 1 and 4 blockade in activated human retinal endothelial cells","volume":"46","author":"Appukuttan","year":"2018","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108104_bib5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1073\/pnas.022630199","article-title":"Reactive oxygen generated by Nox1 triggers the angiogenic switch","volume":"99","author":"Arbiser","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.exer.2020.108104_bib6","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3109\/02713680903205238","article-title":"Beneficial effect of docosahexanoic acid and lutein on retinal structural, metabolic, and functional abnormalities in diabetic rats","volume":"34","author":"Arnal","year":"2009","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2020.108104_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2006.05.064","article-title":"Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2020.108104_bib8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bjophthalmol-2013-304033","article-title":"Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010","volume":"98","author":"Bourne","year":"2014","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108104_bib9","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/eye.2017.64","article-title":"Oxidative stress and diabetic retinopathy: development and treatment","volume":"31","author":"Calderon","year":"2017","journal-title":"Eye"},{"key":"10.1016\/j.exer.2020.108104_bib10","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.ophtha.2013.01.021","article-title":"Long-term effects of vitamins C and E, beta-carotene, and zinc on age-related macular degeneration: AREDS report no. 35","volume":"120","author":"Chew","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2020.108104_bib11","first-page":"S311","article-title":"Addressing unmet needs in diabetic retinopathy","volume":"25","author":"Coney","year":"2019","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.exer.2020.108104_bib12","first-page":"835","article-title":"An exploratory study evaluating the effects of macular carotenoid supplementation in various retinal diseases","volume":"10","author":"Crosby-Nwaobi","year":"2016","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108104_bib13","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1007\/s00417-013-2376-6","article-title":"Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study","volume":"251","author":"Dawczynski","year":"2013","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108104_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10654-017-0338-8","article-title":"Diet and risk of diabetic retinopathy: a systematic review","volume":"33","author":"Dow","year":"2018","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.exer.2020.108104_bib15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1381","article-title":"Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer","volume":"3","author":"Ferrara","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.exer.2020.108104_bib16","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1001\/archopht.1984.01040031330019","article-title":"Age-related macular degeneration and blindness due to neovascular maculopathy","volume":"102","author":"Ferris","year":"1984","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108104_bib17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2337\/diacare.26.1.226","article-title":"Diabetic retinopathy","volume":"26","author":"Fong","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.exer.2020.108104_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/antiox6040100","article-title":"Effects of the macular carotenoid lutein in human retinal pigment epithelial cells","volume":"6","author":"Gong","year":"2017","journal-title":"Antioxidants"},{"key":"10.1016\/j.exer.2020.108104_bib19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3945\/an.116.013177","article-title":"The age-related eye disease 2 study: micronutrients in the treatment of macular degeneration","volume":"8","author":"Gorusupudi","year":"2017","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.exer.2020.108104_bib20","first-page":"1","article-title":"Effects of bevacizumab on the neovascular membrane of proliferative diabetic retinopathy: reduction of endothelial cells and expressions of VEGF and HIF-1alpha","volume":"18","author":"Han","year":"2012","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2020.108104_bib21","first-page":"850","article-title":"Carotenoids in the human macula and whole retina","volume":"29","author":"Handelman","year":"1988","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.108104_bib22","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.2337\/dc18-0707","article-title":"The association between diabetes and age-related macular degeneration among the elderly in taiwan","volume":"41","author":"He","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.exer.2020.108104_bib23","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1167\/iovs.13-12004","article-title":"Roles for redox signaling by NADPH oxidase in hyperglycemia-induced heme oxygenase-1 expression in the diabetic retina","volume":"54","author":"He","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.108104_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2005.10.052","article-title":"Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I\/II multicenter, controlled, multidose study","volume":"113","author":"Heier","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2020.108104_bib25","first-page":"303","article-title":"Application of Lutein and Zeaxanthin in nonproliferative diabetic retinopathy","volume":"4","author":"Hu","year":"2011","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108104_bib26","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1194\/jlr.M056069","article-title":"A lipidomic screen of hyperglycemia-treated HRECs links 12\/15-Lipoxygenase to microvascular dysfunction during diabetic retinopathy via NADPH oxidase","volume":"56","author":"Ibrahim","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.exer.2020.108104_bib27","series-title":"Anonymous New Frontiers in Ophthalmology","first-page":"140","article-title":"Bioavailability of lutein\/zeaxanthin isomers and macular pigment optical density response to macular carotenoid supplementation: a randomized double blind placebo controlled study","author":"Juturu","year":"2016"},{"key":"10.1016\/j.exer.2020.108104_bib28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.freeradbiomed.2012.04.030","article-title":"Puerarin inhibits the retinal pericyte apoptosis induced by advanced glycation end products in vitro and in vivo by inhibiting NADPH oxidase-related oxidative stress","volume":"53","author":"Kim","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.exer.2020.108104_bib29","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/archopht.126.9.1266","article-title":"Inhibition of retinopathy and retinal metabolic abnormalities in diabetic rats with AREDS-based micronutrients","volume":"126","author":"Kowluru","year":"2008","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108104_bib30","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00125-014-3194-z","article-title":"TIAM1-RAC1 signalling axis-mediated activation of NADPH oxidase-2 initiates mitochondrial damage in the development of diabetic retinopathy","volume":"57","author":"Kowluru","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.exer.2020.108104_bib31","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1167\/iovs.07-0764","article-title":"Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats","volume":"49","author":"Kowluru","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.108104_bib32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/exer.1997.0309","article-title":"A one year study of the macular pigment: the effect of 140 days of a lutein supplement","volume":"65","author":"Landrum","year":"1997","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2020.108104_bib33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ophtha.2009.06.040","article-title":"Micronutrients and diabetic retinopathy a systematic review","volume":"117","author":"Lee","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2020.108104_bib34","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.2337\/db09-1057","article-title":"Inhibition of reactive oxygen species by Lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db\/db mice: role of NADPH oxidase 4","volume":"59","author":"Li","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2020.108104_bib35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00417-018-4157-8","article-title":"Activation of the sweet taste receptor T1R3 by sucralose attenuates VEGF-induced vasculogenesis in a cell model of the retinal microvascular endothelium","volume":"257","author":"Lizunkova","year":"2019","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108104_bib36","doi-asserted-by":"crossref","first-page":"e811","DOI":"10.1111\/aos.13769","article-title":"A genome-wide association study suggests new evidence for an association of the NADPH Oxidase 4 (NOX4) gene with severe diabetic retinopathy in type 2 diabetes","volume":"96","author":"Meng","year":"2018","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.exer.2020.108104_bib37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4321\/S0365-66912006000100007","article-title":"Oxidative stress in a model of experimental diabetic retinopathy: the utility of peroxinytrite scavengers","volume":"81","author":"Miranda","year":"2006","journal-title":"Arch. Soc. Esp. Oftalmol."},{"key":"10.1016\/j.exer.2020.108104_bib38","series-title":"Diabetic Retinopathy","year":"2020"},{"key":"10.1016\/j.exer.2020.108104_bib39","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","article-title":"IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040","volume":"128","author":"Ogurtsova","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.exer.2020.108104_bib40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jdiacomp.2011.11.004","article-title":"Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy","volume":"26","author":"Ola","year":"2012","journal-title":"J. Diabet. Complicat."},{"key":"10.1016\/j.exer.2020.108104_bib41","doi-asserted-by":"crossref","DOI":"10.1007\/s11892-017-0913-0","article-title":"Animal models of diabetic retinopathy","volume":"17","author":"Olivares","year":"2017","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.exer.2020.108104_bib42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.mvr.2018.08.002","article-title":"Anti-angiogenic effect of adiponectin in human primary microvascular and macrovascular endothelial cells","volume":"122","author":"Palanisamy","year":"2019","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.exer.2020.108104_bib43","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5301\/ejo.5000069","article-title":"Carotenoids in Age-related Maculopathy Italian Study (CARMIS): two-year results of a randomized study","volume":"22","author":"Piermarocchi","year":"2012","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108104_bib44","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00125-002-0990-7","article-title":"Diabetic retinopathyA clinical update","volume":"45","author":"Porta","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.exer.2020.108104_bib45","doi-asserted-by":"crossref","first-page":"693426","DOI":"10.1155\/2011\/693426","article-title":"Neurovascular interaction and the pathophysiology of diabetic retinopathy","volume":"2011","author":"Qian","year":"2011","journal-title":"Exp. Diabetes Res."},{"key":"10.1016\/j.exer.2020.108104_bib46","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00125-009-1655-6","article-title":"Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes","volume":"53","author":"Sasaki","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.exer.2020.108104_bib47","doi-asserted-by":"crossref","first-page":"865179","DOI":"10.1155\/2015\/865179","article-title":"Lutein, zeaxanthin, and meso-zeaxanthin in the clinical management of eye disease","volume":"2015","author":"Scripsema","year":"2015","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108104_bib48","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1042\/BJ20061903","article-title":"NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation","volume":"406","author":"Serrander","year":"2007","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.exer.2020.108104_bib49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12079-019-00539-1","article-title":"Lutein reverses hyperglycemia-mediated blockage of Nrf2 translocation by modulating the activation of intracellular protein kinases in retinal pigment epithelial (ARPE-19) cells","volume":"14","author":"Shivarudrappa","year":"2019","journal-title":"J. Cell. Commun. Signal."},{"key":"10.1016\/j.exer.2020.108104_bib50","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/157339906775473671","article-title":"Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy","volume":"2","author":"Simo","year":"2006","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.exer.2020.108104_bib51","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ophtha.2007.08.050","article-title":"Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity","volume":"115","author":"Sonmez","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2020.108104_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20120588","article-title":"Advances in our understanding of diabetic retinopathy","volume":"125","author":"Stitt","year":"2013","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.exer.2020.108104_bib53","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ophtha.2018.08.001","article-title":"Rationale and application of the protocol S anti-vascular endothelial growth factor Algorithm for proliferative diabetic retinopathy","volume":"126","author":"Sun","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2020.108104_bib54","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3389\/fphar.2019.01639","article-title":"Inhibition of pathological retinal neovascularization by a small peptide derived from human tissue-type plasminogen kringle 2","volume":"10","author":"Sun","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.exer.2020.108104_bib55","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s40200-019-00434-x","article-title":"Dietary antioxidative supplements and diabetic retinopathy; a systematic review","volume":"18","author":"Tabatabaei-Malazy","year":"2019","journal-title":"J. Diabetes Metab. Disord."},{"key":"10.1016\/j.exer.2020.108104_bib56","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ophtha.2007.03.083","article-title":"Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study","volume":"115","author":"Tan","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2020.108104_bib57","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1167\/iovs.12-10685","article-title":"Lack of the antioxidant glutathione peroxidase-1 (GPx1) exacerbates retinopathy of prematurity in mice","volume":"54","author":"Tan","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.108104_bib58","doi-asserted-by":"crossref","first-page":"343560","DOI":"10.1155\/2013\/343560","article-title":"Pathophysiology of diabetic retinopathy","volume":"2013","author":"Tarr","year":"2013","journal-title":"ISRN Ophthalmol"},{"key":"10.1016\/j.exer.2020.108104_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41433-020-0776-5","article-title":"Do we have enough ophthalmologists to manage vision-threatening diabetic retinopathy? A global perspective","author":"Teo","year":"2020","journal-title":"Eye"},{"key":"10.1016\/j.exer.2020.108104_bib60","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/bjo.2008.146316","article-title":"Association of diabetes with age-related macular degeneration in the EUREYE study","volume":"93","author":"Topouzis","year":"2009","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108104_bib61","doi-asserted-by":"crossref","first-page":"23317","DOI":"10.1074\/jbc.271.38.23317","article-title":"p22phox is a critical component of the superoxide-generating NADH\/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells","volume":"271","author":"Ushio-Fukai","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2020.108104_bib62","first-page":"231","article-title":"Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2-induced intravitreal neovascularization in a rat model of retinopathy of prematurity","volume":"20","author":"Wang","year":"2014","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2020.108104_bib63","doi-asserted-by":"crossref","first-page":"16012","DOI":"10.1038\/nrdp.2016.12","article-title":"Diabetic retinopathy","volume":"2","author":"Wong","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.exer.2020.108104_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196037","article-title":"Attenuation of choroidal neovascularization by dietary intake of omega-3 long-chain polyunsaturated fatty acids and lutein in mice","volume":"13","author":"Yanai","year":"2018","journal-title":"PloS One"}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483520303638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483520303638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:57:43Z","timestamp":1778626663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483520303638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":64,"alternative-id":["S0014483520303638"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2020.108104","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lutein and zeaxanthin attenuates VEGF-induced neovascularisation in human retinal microvascular endothelial cells through a Nox4-dependent pathway","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2020.108104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108104"}}